TRCT
KRTX

Tower Research Capital (TRC)’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-334
Closed -$106K – 6270
2023
Q4 		$106K Sell
334
-1,176
-78% -$229K ﹤0.01% 2611
2023
Q3 		$255K Sell
1,510
-561
-27% -$105K 0.01% 1282
2023
Q2 		$449K Buy
2,071
+131
+7% +$28.1K 0.02% 1051
2023
Q1 		$352K Buy
1,940
+668
+53% +$128K 0.01% 1042
2022
Q4 		$250K Sell
1,272
-6,755
-84% -$1.45M 0.01% 1158
2022
Q3 		$1.8M Buy
8,027
+5,018
+167% +$1.02M 0.03% 458
2022
Q2 		$381K Buy
3,009
+2,212
+278% +$254K 0.01% 1304
2022
Q1 		$101K Sell
797
-2,252
-74% -$254K ﹤0.01% 2192
2021
Q4 		$399K Buy
3,049
+1,530
+101% +$198K 0.01% 1270
2021
Q3 		$186K Sell
1,519
-1,323
-47% -$153K ﹤0.01% 1891
2021
Q2 		$324K Buy
2,842
+2,088
+277% +$244K 0.01% 1534
2021
Q1 		$91K Sell
754
-643
-46% -$72.8K ﹤0.01% 2662
2020
Q4 		$142K Buy
1,397
+527
+61% +$48.8K ﹤0.01% 2031
2020
Q3 		$67K Sell
870
-4,285
-83% -$365K ﹤0.01% 3420
2020
Q2 		$575K Buy
+5,155
New +$448K 0.02% 905

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Tower Research Capital (TRC)'s KRTX Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 334 shares — an estimated $106K sold.

Tower Research Capital (TRC) first reported a position in KRTX in Q2 2020 and held it in 15 quarters. The position peaked at $1.8M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Tower Research Capital (TRC) reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 334 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $106K.
  • Tower Research Capital (TRC) first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Tower Research Capital (TRC)'s Karuna Therapeutics, Inc. Common Stock position peaked at $1.8M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.